MedTrace Logo

NeuroCatch Reference Interval Database

NCT06677424 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 810

Last updated 2024-11-06

No results posted yet for this study

Summary

The purpose of this study is to understand how the brain responds to sounds and words, and how this response varies between individuals. The purpose if this study is to develop data set comparing the results from one individual with those from other members (a reference interval database of NeuroCatch® Platform 2) and to quantify the expected distribution across sex and age. NeuroCatch® Platform 2, is a medical device approved by Health Canada. The plan is to enroll 810 participants, the study includes screening for eligibility and one brain scan. The study is conducted at the Centre for Neurology Studies in Surrey, BC or at its satellite sites ( if required).

Conditions

  • Healthy Controls
  • Brain Function

Interventions

DEVICE

NeuroCatch® Platform 2

The NeuroCatch® Platform 2, a medical device system developed by NeuroCatch Inc., consists of software and hardware that captures brain health information. The platform intends to provide a quick, portable and easy to use solution for the acquisition, display, analysis, storage, reporting and management of electroencephalograph (EEG) and event-related potential (ERP; brain response to a stimulus) information. The device is approved as a medical device by Health Canada.

Sponsors & Collaborators

  • NeuroCatch Inc.

    collaborator INDUSTRY

  • HealthTech Connex Inc.

    lead INDUSTRY

Principal Investigators

  • Jan Venter, MD · Centre for Neurology Studies

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-05
Primary Completion
2025-02-28
Completion
2026-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06677424 on ClinicalTrials.gov